美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Veraxa Biotech Holding AG

1.53

+0.01000.66%

成交量：2.43萬

成交額：3.72萬

市值：2.16億

市盈率：7.14

高：1.59

開：1.56

低：1.50

收：1.52

52周最高：27.36

52周最低：1.27

股本：1.41億

流通股本：4,095.75萬

量比：0.50

換手率：0.06%

股息：- -

股息率：- -

每股收益(TTM):0.2142

每股收益(LYR):-5.8037

淨資產收益率：-871.42%

總資產收益率：-49.99%

市淨率：-11.23

市盈率(LYR):-0.26

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Veraxa Biotech Holding AG

交易所：

NASDAQ

成立時間：

2021

員工人數：

- -

公司地址：

Im Neuenheimer Feld 584,Heidelberg,Baden-Württemberg,Germany

官網：

http://www.veraxa.com

郵編：

69120

電話：

49 6221 3521330

傳真：

- -

簡介：

Veraxa Biotech AG於2025年6月25日在瑞士法律下註冊成立。該公司是一家專註於腫瘤學的生物技術公司，擁有急性髓系白血病的臨床項目，以及用於開發抗體藥物偶聯物和T細胞銜接器的專有平台技術。其目標是建立一個腫瘤學項目管線，旨在為患者實現療效的同時最大限度地減少副作用。

董事

名稱

職位

Adeel Rouf

President, Chief Executive Officer and Director

Warren Hosseinion

Chairman of the Board and Director

Jonathan Intrater

Independent Director

Oded Levy

Independent Director

股東

名稱

職位

Adeel Rouf

President, Chief Executive Officer and Director

Raju Willener

Chief Financial Officer

Christoph Erkel

Chief Scientific Officer

Warren Hosseinion Jr.

Vice President, Mergers and Acquisitions

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/VRXA/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"VRXA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRXA\",,,,,undefined,":{"symbol":"VRXA","market":"US","secType":"STK","nameCN":"Veraxa Biotech Holding AG","latestPrice":1.53,"timestamp":1789572439275,"preClose":1.52,"halted":0,"volume":24300,"delay":0,"changeRate":0.006578947368421058,"floatShares":40957496,"shares":141407813,"eps":0.2142,"marketStatus":"交易中","change":0.01,"latestTime":"09-16 11:27:34 EDT","open":1.56,"high":1.59,"low":1.495,"amount":37228.29498,"amplitude":0.0625,"askPrice":1.54,"askSize":35,"bidPrice":1.47,"bidSize":106,"shortable":3,"etf":0,"ttmEps":0.2142,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":1.52,"preHourTrading":{"tag":"盘前","latestPrice":1.54,"preClose":1.52,"latestTime":"09:08 EDT","volume":4114,"amount":6786.946023,"timestamp":1789564081073,"change":0.02,"changeRate":0.013158,"amplitude":0.105263},"postHourTrading":{"tag":"盘后","latestPrice":1.52,"preClose":1.52,"latestTime":"19:30 EDT","volume":114,"amount":174.5,"timestamp":1789515005036,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.504982},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRXA\",,,,,undefined,":{"symbol":"VRXA","floatShares":40957496,"roa":"-49.99%","roe":"-871.42%","lyrEps":-5.803658,"volumeRatio":0.504982,"shares":141407813,"dividePrice":0,"high":1.59,"amplitude":0.0625,"preClose":1.52,"low":1.495,"week52Low":1.27,"pbRate":"-11.23","psRate":"7561.06","week52High":27.36,"institutionHeld":0,"latestPrice":1.53,"committee":0.503546,"eps":0.2142,"divideRate":0,"volume":24300,"delay":0,"ttmEps":0.2142,"open":1.56,"prevYearClose":18.65,"prevWeekClose":1.65,"prevMonthClose":1.35,"prevQuarterClose":1.88,"fiveDayClose":1.59,"twentyDayClose":1.79,"sixtyDayClose":4.14},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VRXA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VRXA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VRXA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VRXA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VRXA","date":"2026-09-15","current":7.142857,"percent":0.176471,"low":-3.022108,"twenty":-2.801269,"median":-1.377349,"eighty":-1.094949,"high":-0.413162,"avg":-1.785283,"sd":0.924748,"marketCap":230494735},"quantilePoints":[{"date":"2026-08-21","current":-1.35335,"twenty":-1.349054,"median":-1.34261,"eighty":-1.336165,"marketCap":47660725},{"date":"2026-08-28","current":-1.03732,"twenty":-1.349054,"median":-1.281094,"eighty":-1.194963,"marketCap":36312933},{"date":"2026-09-04","current":-2.622384,"twenty":-1.391748,"median":-1.265172,"eighty":-0.552029,"marketCap":216353953},{"date":"2026-09-11","current":-2.842124,"twenty":-2.738773,"median":-1.34261,"eighty":-1.03732,"marketCap":233322891},{"date":"2026-09-15","current":-2.834144,"twenty":-2.801269,"median":-1.377349,"eighty":-1.094949,"marketCap":230494735}],"updateTime":1789572454649},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":699307581,"yearFounded":2021,"address":"Im Neuenheimer Feld 584,Heidelberg,Baden-Württemberg,Germany","zipCode":"69120","officePhone":"49 6221 3521330","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.veraxa.com","stockEarnings":[{"period":"1week","weight":-0.05},{"period":"1month","weight":-0.1872},{"period":"3month","weight":-0.7406},{"period":"6month","weight":-0.9185},{"period":"ytd","weight":-0.9185}],"compareEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":-0.0244},{"period":"3month","weight":0.0222},{"period":"6month","weight":0.1479},{"period":"1year","weight":0.146},{"period":"ytd","weight":0.1107}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Veraxa Biotech AG於2025年6月25日在瑞士法律下註冊成立。該公司是一家專註於腫瘤學的生物技術公司，擁有急性髓系白血病的臨床項目，以及用於開發抗體藥物偶聯物和T細胞銜接器的專有平台技術。其目標是建立一個腫瘤學項目管線，旨在為患者實現療效的同時最大限度地減少副作用。","exchange":"NASDAQ","name":"Veraxa Biotech Holding AG","nameEN":"Veraxa Biotech Holding AG"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"VRXA\",market:\"US\",,,undefined,":{"directors":[{"name":"Adeel Rouf","position":"President, Chief Executive Officer and Director"},{"name":"Warren Hosseinion","position":"Chairman of the Board and Director"},{"name":"Jonathan Intrater","position":"Independent Director"},{"name":"Oded Levy","position":"Independent Director"}],"executives":[{"name":"Adeel Rouf","position":"President, Chief Executive Officer and Director"},{"name":"Raju Willener","position":"Chief Financial Officer"},{"name":"Christoph Erkel","position":"Chief Scientific Officer"},{"name":"Warren Hosseinion Jr.","position":"Vice President, Mergers and Acquisitions"}]}}}